CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results

Core Insights - Vext Science, Inc. reported financial results for Q3 2025, correcting previous inaccuracies in EBITDA and Adjusted EBITDA figures [2][3] - The company achieved a revenue of $12.7 million, representing a 41% year-over-year increase, driven by expanded operations in Ohio and stable performance in Arizona [4][7] - Year-to-date operating cash flow reached $8.5 million, a significant improvement compared to $(0.7) million in the same period last year [7] Financial Performance - Corrected Q3 2025 financial results include: - Revenue: $12,670,000 - EBITDA: $1,828,000 - Adjusted EBITDA: $1,625,000 - Adjusted EBITDA Margin: 12.8% [5][14] - Comparison with previous quarters: - Q2 2025 Revenue: $13,407,000; EBITDA: $5,263,000; Adjusted EBITDA: $4,077,000; Adjusted EBITDA Margin: 30% [5][14] - Q3 2024 Revenue: $8,987,000; EBITDA: $1,925,000; Adjusted EBITDA: $2,873,000; Adjusted EBITDA Margin: 32% [5][14] Operational Highlights - The company expanded its retail footprint in Ohio to five locations, with plans to reach a total of eight dispensaries by 2026 [6][7] - Vext's operations in Arizona continued to outperform state averages on a per-store basis, maintaining steady performance despite market challenges [6][7] - Management expressed confidence in sustaining operational momentum and improving cash flow in Q4 2025 [6][8] Recent Developments - On September 17, 2025, Vext received regulatory approval to transfer ownership of the Herbal Wellness Center dispensary in Portsmouth, Ohio, completing the transfer on October 1, 2025 [9]